[Multiple cerebral haemorrhages and antiplatelet drugs].
J
J
Rubí-Callejón
A
A
Arjona
P J
PJ
Serrano-Castro
D001241:Aspirin / Q000009:adverse effects* / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000139:chemically induced*; D004878:Ergotamine / Q000627:therapeutic use; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012307:Risk Factors; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D014662:Vasoconstrictor Agents; D004878:Ergotamine; D001241:Aspirin